BlackRock Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $130K | Buy |
41,078
+2,427
| +6% | +$7.68K | ﹤0.01% | 2838 |
|
|
2016
Q3 | $132K | Buy |
38,651
+4,148
| +12% | +$14.2K | ﹤0.01% | 2833 |
|
|
2016
Q2 | $79K | Buy |
34,503
+5,033
| +17% | +$11.5K | ﹤0.01% | 3016 |
|
|
2016
Q1 | $74K | Sell |
29,470
-2,475
| -8% | -$6.22K | ﹤0.01% | 2998 |
|
|
2015
Q4 | $106K | Sell |
31,945
-10,631
| -25% | -$35.3K | ﹤0.01% | 2852 |
|
|
2015
Q3 | $103K | Sell |
42,576
-5,765
| -12% | -$13.9K | ﹤0.01% | 3044 |
|
|
2015
Q2 | $142K | Buy |
48,341
+4,910
| +11% | +$14.4K | ﹤0.01% | 2969 |
|
|
2015
Q1 | $174K | Buy |
43,431
+4,644
| +12% | +$18.6K | ﹤0.01% | 2728 |
|
|
2014
Q4 | $117K | Sell |
38,787
-1,667
| -4% | -$5.03K | ﹤0.01% | 2920 |
|
|
2014
Q3 | $103K | Sell |
40,454
-148,749
| -79% | -$379K | ﹤0.01% | 2950 |
|
|
2014
Q2 | $466K | Buy |
189,203
+1,701
| +0.9% | +$4.19K | ﹤0.01% | 2029 |
|
|
2014
Q1 | $498K | Buy |
187,502
+151,405
| +419% | +$402K | ﹤0.01% | 2025 |
|
|
2013
Q4 | $105K | Buy |
36,097
+4,868
| +16% | +$14.2K | ﹤0.01% | 2996 |
|
|
2013
Q3 | $96K | Buy |
31,229
+2,516
| +9% | +$7.73K | ﹤0.01% | 2971 |
|
|
2013
Q2 | $92K | Buy |
+28,713
| New | +$92K | ﹤0.01% | 2938 |
|